Heart Failure with Carfilzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials

被引:8
|
作者
Rahman, M. Rubayat [1 ]
Ball, Somedeb [1 ]
Paz, Pablo [1 ]
Elmassry, Mohamed [1 ]
Vutthikraivit, Wasawat [1 ]
Bandyopadhyay, Dhrubajyoti [2 ]
Lavie, Carl J. [3 ]
Fonarow, Gregg C. [4 ]
机构
[1] Texas Tech Univ, Dept Internal Med, Hlth Sci Ctr, Lubbock, TX 79409 USA
[2] Icahn Sch Med Mt Sinai, Dept Internal Med, Mt Sinai St Lukes West Hosp, New York, NY 10029 USA
[3] John Ochsner Heart & Vasc Inst, Ochsner Clin, Cardiac Rehabil & Prevent Cardiol, New Orleans, LA USA
[4] Univ Calif Los Angeles, Div Cardiovasc Med, Los Angeles, CA USA
关键词
D O I
10.1016/j.cardfail.2020.07.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:610 / 612
页数:3
相关论文
共 50 条
  • [1] Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
    Somedeb Ball
    Tapas Ranjan Behera
    Faiz Anwer
    Rajshekhar Chakraborty
    Annals of Hematology, 2020, 99 : 1265 - 1271
  • [2] Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Anwer, Faiz
    Chakraborty, Rajshekhar
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1265 - 1271
  • [3] Risk of Renal Toxicities With Carfilzomib In Patients With Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Adhikari, Nimesh
    Anwer, Faiz
    Chakraborty, Rajshekhar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S332 - S332
  • [4] Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ball, Somedeb
    Behera, Tapas Ranjan
    Wongsaengsak, Sariya
    Khandelwal, Nuvneet
    Chakraborty, Rajshekhar
    BLOOD, 2019, 134
  • [5] Risk of Renal Toxicities with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Ball, Somedeb
    Anwer, Faiz
    Behera, Tapas Ranjan
    Chakraborty, Rajshekhar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E114 - E115
  • [6] RISK OF HEART FAILURE WITH CARFILZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Paz, Pablo
    Vutthikraivit, Wasawat
    Mantilla, Barbara
    El Nawaa, Saif
    Wongsanegsak, Sally
    Elmassry, Mohamed
    Rahman, M. Rubayat
    Whisenant, Ty
    Ball, Somedeb
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 986 - 986
  • [7] Infection risk with carfilzomib in multiple myeloma: a systematic review and meta-analysis of randomised controlled trials
    Wongsaengsak, Sariya
    Kopel, Jonathan
    Behera, Tapas R.
    Chakraborty, Rajshekhar
    Ball, Somedeb
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : E95 - E97
  • [8] Telemonitoring in heart failure patients: Systematic review and meta-analysis of randomized controlled trials
    Umeh, Chukwuemeka Anthony
    Torbela, Adrian
    Saigal, Shipra
    Kaur, Harpreet
    Kazourra, Shadi
    Gupta, Rahul
    Shah, Shivang
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (12): : 640 - 656
  • [9] Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure
    Lipinski, Michael J.
    Cauthen, Clay A.
    Biondi-Zoccai, Giuseppe G. L.
    Abbate, Antonio
    Vrtovec, Bojan
    Khan, Bobby V.
    Vetrovec, George W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (12): : 1708 - 1716
  • [10] Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials
    Tao, Jianping
    Liu, Xiaoyong
    Bai, Wenwei
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11